NCT03883087 2023-04-03
A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I Mutation
Ascentage Pharma Group Inc.
Phase 2 Unknown
Clinical Trials
4 trialsNCT05353205 2022-04-29
A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 4 Unknown
NCT02885766 2020-02-17
Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene
Fusion Pharma LLC
Phase 1/2 Unknown
NCT02949570 2016-10-31
ICT10
Hybrigenics Corporation
Phase 2 Unknown